Source: Benzinga

Merck: April 14, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRK

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE:MRK).Shareholders who purchased shares of MRK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/merck-co-inc-loss-submission-form/?id=142490&from=3CLASS PERIOD: February 3, 2022 to February 3, 2025ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning Merck's expected revenue of $11 billion from sales of Gardasil by 2030. Defendants' statements included, among other things, confidence in Merck's purported ability to utilize successful consumer activation and education efforts on the benefits of Gardasil in order to drive demand and capitalize on eligible populations for vaccination, resulting in confidently optimistic reports and forecasts of Gardasil's growth in ...Full story available on Benzinga.com

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Robert M. Davis's photo - Chairman & CEO of Merck

Chairman & CEO

Robert M. Davis

CEO Approval Rating

78/100

Read more